State of the art, nomenclature, and points of consensus and controversy concerning benign melanocytic lesions: Outcome of an international workshop

Advances in Anatomic Pathology

Volumn 17, Issue 2, 2010, Pages 73-90

  Barnhill, Raymond L ^a   Cerroni, Lorenzo ^b   Cook, Martin ^c   Elder, David E ^d   Kerl, Helmut ^b   Leboit, Philip E ^e   McCarthy, Stanley W ^f   Mihm, Martin C ^g   Mooi, Wolter J ^h   Piepkorn, Michael W ⁱ   Prieto, Victor G ^j   Scolyer, Richard A ^f  

^a SAINT LOUIS HOSPITAL   (France)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h VU UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

^j UNIVERSITY OF TEXAS   (United States)

more..

Author keywords

Atypical nevus; Benign melanocytic neoplasms; Benign melanocytic tumors; Blue nevus; Congenital nevus; Dysplastic nevus; Hopconsensus conference; Melanocytic nevus; Melanoma; Nevi; Nevocellular nevi; Spindle cell nevus; Spitz nevus; Works

Indexed keywords

ACANTHOSIS; BLUE NEVUS; CANCER RESEARCH; CONGENITAL NEVUS; DYSPLASTIC NEVUS; EPIDERMIS; GENETIC HETEROGENEITY; HISTOPATHOLOGY; HUMAN; JUVENILE MELANOMA; MELANOCYTIC NEVUS; MELANOCYTOSIS; NEVUS CELL; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SKIN DEFECT;

CHILD; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; DYSPLASTIC NEVUS SYNDROME; HUMANS; INFANT, NEWBORN; NEVUS, BLUE; NEVUS, EPITHELIOID AND SPINDLE CELL; NEVUS, PIGMENTED; SKIN NEOPLASMS;

EID: 77649110100     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/PAP.0b013e3181cfe758     Document Type: Review

References (105)

1. Lund HS, Stobbe GD. The natural history of the pigmented nevus: factors of age and anatomic location. Am J Pathol. 1949;25:1117-1155.
2. Elder DE, Murphy GF. Melanocytic tumors of the skin. Atlas of tumor pathology. AFIP. 1990:1-101.
3. Mihm MC Jr, Googe PB. Problematic Pigmented Lesions. Philadelphia: Lea and Feiger; 1990.
4. Crowson AN, Magro CM, Mihm MC, Jr. The Melanocytic Proliferations: A Comprehensive Textbook of Pigmented Lesions. New York: Wiley-Liss; 2001.
5. Mooi WJ, Krausz T. Pathology of Melanocytic Disorders. 2nd ed. Oxford University Press: Oxford, UK; 2007.
6. Barnhill RL, Piepkorn M, Busam KJ. Pathology of Melanocytic Nevi and Malignant Melanoma. 2nd ed. New York: Springer-Verlag; 2004.
7. Barnhill RL. Tumors of Melanocytes in Dermatopathology. In: Barnhill RL, Crowson AN, Magro CM, et al, eds. 3rd ed. New York: McGraw-Hill; 2010:615-688.
8. Reed RJ, Ichinose H, Clark WH Jr, et al. Common and uncommon melanocytic nevi and borderline melanomas. Semin Oncol. 1975;2:119-147.
9. Wayte DM, Helwig EB. Halo nevi. Cancer. 1968;22:69-90.
10. FallowfieldME, Collina G, Cook MG. Melanocytic lesions of the palm and sole. Histopathology. 1994;24:463-467.
11. Signoretti S, Annessi G, Puddu P, et al. Melanocytic nevi of palms and soles: a histological study according to the plane of section. Am J Surg Pathol. 1999;23:283-287.
12. Khalifeh I, Taraif S, Reed JA, et al. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ. Am J Surg Pathol. 2007;31:1130-1136.
13. Clark WH Jr, Hood AJ, Tucker MA, et al. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia. Hum Pathol. 1998;29(suppl 1):S1-S24.
14. Gleason BC, Hirsch MS, Nucci MR, et al. Atypical genital nevi. A clinicopathologic analysis of 56 cases. Am J Surg Pathol. 2008;32:51-57.
15. Rongioletti F, Ball RA, Marcus R, et al. Histopathological features of flexural melanocytic nevi: a Study of 40 Cases. J Cutan Pathol. 2000;27:215-217.
16. Rongioletti F, Urso C, Batolo D, et al. Melanocytic nevi of the breast: A histologic case-control study. J Cutan Pathol. 2004;31:137-140.
17. Tucker MA, Greene MH, Clark WH Jr, et al. Dysplastic nevi on the scalp of prepubertal children from melanoma-prone families. J Pediatr. 1983; 103:65-69.
18. Fernandez M, Raimer SS, Sá nchez RL. Dysplastic nevi of the scalp and forehead in children. Pediatr Dermatol. 2001; 18:5-8.
19. Fabrizi G, Pagliarello C, Parente P, et al. Atypical nevi of the scalp in adolescents. J Cutan Pathol. 2007;34:365-369.
20. Clark WH Jr, Reimer RR, Greene M, et al. Origin of familial malignant melanomas from heritable melanocytic lesions: the B-K mole syndrome. Arch Dermatol. 1978;114:732-738.
21. Elder DE, Goldman LI, Goldman SC, et al. Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma. Cancer. 1980;46:1787-1794.
22. NIH Consensus Conference: precursors to malignant melanoma. JAMA. 1984;251:1864-1866.
23. Elder DE. The dysplastic nevus. Pathology. 1985;17:291-297.
24. Seywright MM, Doherty VR, MacKie RM. Proposed alternative terminology and subclassification of so-called "dysplastic naevi". J Clin Pathol. 1986;39:189-194.
25. Bergman W, Ruiter DJ, Scheffer E, et al. Melanocytic atypia in dysplastic nevi: immunohistochemical and cytophotometrical analysis. Cancer. 1988;61:1660-1666.
26. Steijlen PM, Bergman W, Hermans J, et al. The efficacy of histopathological criteria required for diagnosing dysplastic naevi. Histopathology. 1988;12:289-300.
27. Piepkorn M, Meyer LJ, Goldgar D. The dysplastic melanocytic nevus-a prevalent lesion that correlates poorly with clinical phenotype. J Am Acad Dermatol. 1989;20:407-415.
28. Barnhill RL, Roush GC, Duray PH. Correlation of histologic and cytoplasmic features with nuclear atypia in atypical (dysplastic) nevomelanocytic nevi. Hum Pathol. 1990;21:51-58.
29. Barnhill RL. Current status of the dysplastic melanocytic nevus. J Cutan Pathol. 1991;18:147-159.
30. Duray PH, DerSimonian R, Barnhill RL, et al. An analysis of interobserver recognition of the histopathologic features of dysplastic nevi from a mixed group of nevomelanocytic lesions. J Am Acad Dermatol. 1992;27:741-749.
31. NIH Consensus Development Panel on Early Melanoma: diagnosis and treatment of early melanoma. JAMA. 1992;268: 1314-1319.
32. Duncan LM, Berwick MA, Bruijn JA, et al. Histopathologic recognition and grading of dysplastic melanocytic nevi: an inter-observer agreement study. J Invest Dermatol. 1993; 100(suppl 3):318S-321S.
33. Piepkorn MW, Barnhill RL, Rabkin MS, et al. Histologic diagnosis of the dysplastic nevus: an analysis of inter-and intra-observer concordance, correlation with clinical phenotype, and prevalence in population controls. J Am Acad Dermatol. 1994;30:707-714.
34. Schmidt B, Hollister K,Weinberg D, et al. Analysis of dysplastic nevi by DNA image cytometry. Cancer. 1994;73:2971-2977.
35. Kang S, Barnhill RL, Mihm MC Jr, et al. Melanoma risk in individuals with clinically atypical nevi. Arch Dermatol. 1994;130:999-1001.
36. Garbe C, Buttner P, Weiss J, et al. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the central malignant melanoma registry of the German Dermatological Society. J Invest Dermatol. 1994;102:695-699. (Pubitemid 24144245)
37. Garbe C, Buttner P, Weiss J, et al. Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: multicenter case-control study of the central malignant melanoma registry of the German Dermatological Society. J Invest Dermatol. 1994;102:700-705.
38. Tucker MA, Halpern A, Holly EA, et al. Clinically recognized dysplastic nevi: a central risk factor for cutaneous melanoma. JAMA. 1997;277:1439-1444.
39. Blessing K. Benign atypical naevi: diagnostic difficulties and continued controversy:. Histopathology. 1999;34:189-198.
40. Shea CR, Vollmer RT, Prieto VG. Correlating architectural disorder and cytological atypia in Clark (dysplastic) melanocytic nevi. Hum Pathol. 1999;30:500-505.
41. Shors AR, Kim S, White E, et al. Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma. Br J Dermatol. 2006;155:988-993.
42. Mark GJ, Mihm MC, Liteplo MG, et al. Congenital melanocytic nevi of the small and garment type. Hum Pathol. 1973;4:395-418.
43. Cramer SF. The melanocytic differentiation pathway in congenital melanocytic nevi: theoretical considerations. Pediatr Pathol. 1988;8:253-265.
44. Reed RJ. Giant congenital nevi: a conceptualization of patterns. J Invest Dermatol. 1993;100(suppl):300S-312S.
45. Barnhill RL, Fleischli M. Histologic features of congenital melanocytic nevi in infants less than a year of age. J Am Acad Dermatol. 1995;33:780-785.
46. Silvers DN, Helwig EB. Melanocytic nevi in neonates. J Am Acad Dermatol. 1981;4:166-175.
47. Hendrickson MR, Ross JC. Neoplasms arising in congenital giant nevi: morphologic study of seven cases and a review of the literature. Am J Surg Pathol. 1981;5:109-135.
48. Mancianti ML, Clark WH, Hayes FA, et al. Malignant melanoma simulants arising in congenital melanocytic nevi do not show experimental evidence for a malignant phenotype. Am J Pathol. 1990;136:817-829.
49. Clark WH Jr, Elder DE, Guerry D. IV: Dysplastic nevi and malignant melanoma. In: Farmer ER, Hood AF, eds. Pathology of the Skin. Norwalk, CT: Appleton and Lange; 1990:684-756.
50. Bastian BC, Xiong J, Frieden IJ, et al. Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanoma. Am J Pathol. 2002;161:1163-1169.
51. Zaal LH, Mooi WJ, Sillevis Smitt JH, et al. Classification of congenital melanocytic naevi and malignant transformation: a review of the literature. Br J Plast Surg. 2004;57:707-719.
52. Bauer J, Curtin JC, Pinkel D, et al. Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations. J Invest Dermatol. 2007;127:179-182.
53. Spitz S. Melanomas of childhood. Am J Pathol. 1948; 24:591-609.
54. Weedon D, Little J. Spindle and epithelioid cell nevi in children and adults. A review of 211 cases of the Spitz nevus. Cancer. 1977;40:217-225.
55. Paniago-Pereira C, Maize J, Ackerman A. Nevus of large spindle and/or epithelioid cells (Spitz's nevus). Arch Dermatol. 1978;114:1811-1823.
56. Busam KJ, Barnhill RL. The spectrum of spitz tumors. In: Kirkham N, Lemoine NR, eds. Progress in Pathology. Vol.2. Edinburgh: Churchill Livingstone; 1995:31-46.
57. Barr R, Morales R, Graham J. Desmoplastic nevus. A distinct histologic variant of mixed spindle and epithelioid cell nevus. Cancer. 1980;46:557-564.
58. MacKie RM, Doherty VR. The desmoplastic melanocytic naevus: a distinct histological entity. Histopathology. 1992; 20:207-211.
59. Harris GR, Shea CR, Horenstein MG, et al. Desmoplastic (sclerotic) nevus an underrecognized entity that resembles dermatofibroma and desmoplastic melanoma. Am J Surg Pathol. 1999;23:786-794.
60. Sagebiel R, Chinn E, Egbert B. Pigmented spindle cell nevus. Clinical and histologic review of 90 cases. Am J Surg Pathol. 1984;8:645-653.
61. Smith N. The pigmented spindle cell tumor of Reed: an underdiagnosed lesion. Semin Diagn Pathol. 1987;4:75-87.
62. Barnhill RL, Mihm MC. Pigmented spindle cell nevus and its variants: distinction from melanoma. Br J Dermatol. 1989; 121:717-726.
63. Barnhill RL, Berwick M, Mihm MC Jr. The histologic spectrum of pigmented spindle cell nevus: a review of 120 cases with emphasis on atypical variants. Hum Pathol. 1991; 22:52-58.
64. Harvell JD, Meehan SA, LeBoit PE. Spitz's nevi with halo reaction: a histopathological study of 17 cases. J Cutan Pathol. 1997;24:611-619.
65. Harvell JD, Bastian BC, LeBoit PE. Persistent (recurrent) Spitz nevi: a histopathologic, immunohistochemical, and molecular pathologic study of 22 cases. Am J Surg Pathol. 2002;26:654-661.
66. Smith K, Barrett T, Skelton H, et al. Spindle cell and epithelioid cell nevi with atypia and metastasis (malignant Spitz nevus). Am J Surg Pathol. 1989;13:931-939.
67. Busam KJ, Barnhill RL. Pagetoid Spitz nevus. Am J Surg Pathol. 1995;19:1061-1067.
68. Barnhill RL, Argenyi ZB, From L, et al. Atypical Spitz nevi/ tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol. 1999;30: 513-520.
69. Spatz A, Calonje E, Handfield-Jones S, et al. Spitz tumors in children: a grading system for risk stratification. Arch Dermatol. 1999;135:282-285.
70. Bastian BC, Wesselman U, Pinkel D, et al. Molecular cytogenetic analysis of Spitz nevus shows clear differences to melanoma. J Invest Dermatol. 1999;113:1065-1069.
71. Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathologic features. Am J Pathol. 2000;157:967-972.
72. Ludgate MW, Fullen DR, Lee J, et al. The atypical Spitz tumor of uncertain biologic potential. A series of 67 patients from a single institution. Cancer. 2009;115:631-641.
73. Montgomery H. The blue nevus (Jadassohn-Tiéche): its distinction from ordinary moles and malignant melanomas. Am J Cancer. 1939;36:527-539.
74. Allen AC. A reorientation on the histogenesis and clinical significance of cutaneous nevi and melanomas. Cancer. 1949; 2:28-56.
75. Dorsey CS, Montgomery H. Blue nevus and its distinction from Mongolian spot and the nevus of Ota. J Invest Dermatol. 1954;22:225-236.
76. Lund HZ, Kraus JM. Melanotic Tumors of the Skin. Atlas of Tumor Pathology. Washington, DC: Armed Forces Institute of Pathology; 1962;104-106.
77. Gartmann H. Neuronaevus blue Masson-cellular blue nevus Allen. Arch Klin Exp Dermatol. 1965;221:109-121.
78. Leopold JG, Richards DB. Cellular blue nevi. J Pathol Bacteriol. 1967;94:247-255.
79. Leopold JG, Richards DB. The interrelationship of blue and common naevi. J Pathol Bacteriol. 1968;95:37-46.
80. Rodriguez HA, Ackerman LV. Cellular blue nevus. clinicopathologic study of forty-five cases. Cancer. 1968;21:393-405.
81. Merkow LP, Burt RC, Hayeslip DW, et al. A cellular and malignant blue nevus: a light and electron Microscopic Study. Cancer. 1969;24:888-896.
82. Mishima Y, Mevorah B. Nevus of Ota and nevus of Ito in American Negroes. J Invest Dermatol. 1961;36:133-154.
83. Kopf AW, Weidman AI. Nevus of Ota. Arch Dermatol. 1962; 85:195-208.
84. Hidano A, Kajima H, Ikeda S, et al. Natural history of nevus of Ota. Arch Dermatol. 1967;95:187-195.
85. Hirayama T, Suzuki T. A new classification of Ota's nevus based on histopathological features. Dermatologica. 1991;183: 169-172.
86. Pittman JL, Fisher BK. Plaque-type blue nevus. Arch Dermatol 1976;112:1127-1128.
87. Carney JA, Ferreiro JA. The epithelioid blue nevus: a multicentric familial tumor with important associations, including cardiac myxoma and psammomatous melanotic schwannoma. Am J Surg Pathol. 1996;20:259-272.
88. Zembowicz A, Carney JA, Mihm MC. Pigmented epithelioid melanocytoma: a low-grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus. Am J Surg Pathol. 2004;28:31-40.
89. Zembowicz A, Knoepp SM, Bei T, et al. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions. Am J Surg Pathol. 2007;31:1764-1775.
90. Seab JA Jr, Graham JH, Helwig EB. Deep penetrating nevus. Am J Surg Pathol. 1989;13:39-44.
91. Barnhill RL, Mihm MC Jr, Magro CM. Plexiform pigmented spindle cell naevus: a distinctive variant of plexiform melanocytic naevus. Histopathology. 1991;18:243-247.
92. Cooper PH. Deep penetrating (plexiform spindle cell) nevus. A frequent participant in combined nevus. J Cutan Pathol. 1992;19:172-180.
93. Fletcher V, Sagebiel RW. The combined nevus: mixed patterns of benign melanocytic lesions must be differentiated from malignant melanomas. In: Ackerman AB, ed. Pathology of Malignant Melanoma. New York: Masson; 1981:273-283.
94. Rogers GS, Advani H, Ackerman AB. A combined variant of Spitz's nevi. how to differentiate them from malignant melanomas. Am J Dermatopathol. 1985;7:61-78.
95. Pulitzer DR, Martin PC, Cohen AP, et al. Histologic classification of the combined nevus. Analysis of the variable expression of melanocytic nevi. Am J Surg Pathol. 1991;15:1111-1122.
96. Scolyer RA, Zhuang L, Palmer AA, et al. Combined naevus: a benign lesion frequently misdiagnosed both clinically and pathologically as melanoma. Pathology. 2004;36:419-427.
97. Barnhill RL, Argenyi Z, Berwick M, et al. Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("Malignant Blue Nevus"). Am J Surg Pathol. 2008;32:36-134
98. Maize JC Jr, McCalmont TH, Carlson JA, et al. Genomic analysis of blue nevi and related dermal melanocytic proliferations. Am J Surg Pathol. 2005;29:1214-1224.
99. Ball NJ, Golitz LE. Melanocytic nevi with focal atypical epithelioid cell components: a review of seventy-three cases. J Am Acad Dermatol. 1994;30:724-729.
100. High WA, Alanen KW, Golitz LE. Is melanocytic nevus with focal atypical epithelioid components (clonal nevus) a superficial variant of deep penetrating nevus? J Am Acad Dermatol. 2006;55:460-466.
101. Murali R, McCarthy SW, Thompson JF, et al. Melanocytic nevus with focal atypical epithelioid components (clonal nevus) is a combined nevus. J Am Acad Dermatol. 2007;56: 889-890.
102. Collina G, Deen S, Cliff S, et al. Atypical dermal nodules in benign melanocytic naevi. Histopathology. 1997;31:77-101.
103. Robson A, Morley-Quante M, Hempel H, et al. Deep penetrating naevus: clinicopathological study of 31 cases with further delineation of histological features allowing distinction from other pigmented benign melanocytic lesions and melanoma. Histopathology. 2003;43:529-537.
104. Cerroni L, Kerl H. Tutorial on melanocytic lesions. Am J Dermatopathol. 2001;23:237-241.
105. Elder DE, Xu X. The approach to the patient with a difficult melanocytic lesion. Pathology. 2004;36:428-434.